b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2613400/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613400/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Microbiology" /><meta name="citation_title" content="The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus" /><meta name="citation_authors" content="Feng Mu, Dongsheng Niu, Jingsong Mu, Bo He, Weiguo Han, Baoxing Fan, Shengyong Huang, Yan Qiu, Bo You, Weijun Chen" /><meta name="citation_date" content="2008" /><meta name="citation_volume" content="8" /><meta name="citation_doi" content="10.1186/1471-2180-8-207" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2613400/?report=abstract" /><meta name="citation_pmid" content="19038059" /><meta name="DC.Title" content="The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Feng Mu" /><meta name="DC.Contributor" content="Dongsheng Niu" /><meta name="DC.Contributor" content="Jingsong Mu" /><meta name="DC.Contributor" content="Bo He" /><meta name="DC.Contributor" content="Weiguo Han" /><meta name="DC.Contributor" content="Baoxing Fan" /><meta name="DC.Contributor" content="Shengyong Huang" /><meta name="DC.Contributor" content="Yan Qiu" /><meta name="DC.Contributor" content="Bo You" /><meta name="DC.Contributor" content="Weijun Chen" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1186/1471-2180-8-207" /><meta name="DC.Language" content="en" /><meta property="og:title" content="The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus" /><meta property="og:type" content="article" /><meta property="og:description" content="In the absence of effective drugs, controlling SARS relies on the rapid identification of cases and appropriate management of the close contacts, or effective vaccines for SARS. Therefore, developing specific and sensitive laboratory tests for SARS as ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613400/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2613400/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2613400/pdf/12866_2008_Article_640.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A6DD3E99C19110000000000C200C2.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2613400</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Microbiology</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Microbiol</span>. 2008; 8: 207. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Nov 28. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2180-8-207" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2180-8-207</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2613400</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19038059">19038059</a></div></div></div></div><h1 class="content-title">The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Mu%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784371140032" co-class="co-affbox">Feng Mu</a>,<sup>#</sup><sup>1</sup> <a href="/pubmed/?term=Niu%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784412259408" co-class="co-affbox">Dongsheng Niu</a>,<sup>#</sup><sup>2</sup> <a href="/pubmed/?term=Mu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784372251920" co-class="co-affbox">Jingsong Mu</a>,<sup>#</sup><sup>3</sup> <a href="/pubmed/?term=He%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784372249536" co-class="co-affbox">Bo He</a>,<sup>1</sup> <a href="/pubmed/?term=Han%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784367477856" co-class="co-affbox">Weiguo Han</a>,<sup>2</sup> <a href="/pubmed/?term=Fan%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784367475488" co-class="co-affbox">Baoxing Fan</a>,<sup>4</sup> <a href="/pubmed/?term=Huang%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784374512592" co-class="co-affbox">Shengyong Huang</a>,<sup>1</sup> <a href="/pubmed/?term=Qiu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784373073280" co-class="co-affbox">Yan Qiu</a>,<sup>5</sup> <a href="/pubmed/?term=You%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784373070912" co-class="co-affbox">Bo You</a>,<sup>1</sup> and  <a href="/pubmed/?term=Chen%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059" class="affpopup" co-rid="_co_idm139784367515424" co-class="co-affbox">Weijun Chen</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139784371140032"><h3 class="no_margin">Feng Mu</h3><p><sup>1</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Airport industry B6, Beijing, 101300 PR China </p><div>Find articles by <a href="/pubmed/?term=Mu%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Feng Mu</a></div></div><div id="_co_idm139784412259408"><h3 class="no_margin">Dongsheng Niu</h3><p><sup>2</sup>State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Millitary Medical Sciences, Dongdajie Road 20, Beijing, 100071 PR China </p><div>Find articles by <a href="/pubmed/?term=Niu%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Dongsheng Niu</a></div></div><div id="_co_idm139784372251920"><h3 class="no_margin">Jingsong Mu</h3><p><sup>3</sup>302 Hospital, Fengtai Road 26, Beijing, 100853 PR China </p><div>Find articles by <a href="/pubmed/?term=Mu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Jingsong Mu</a></div></div><div id="_co_idm139784372249536"><h3 class="no_margin">Bo He</h3><p><sup>1</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Airport industry B6, Beijing, 101300 PR China </p><div>Find articles by <a href="/pubmed/?term=He%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Bo He</a></div></div><div id="_co_idm139784367477856"><h3 class="no_margin">Weiguo Han</h3><p><sup>2</sup>State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Millitary Medical Sciences, Dongdajie Road 20, Beijing, 100071 PR China </p><div>Find articles by <a href="/pubmed/?term=Han%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Weiguo Han</a></div></div><div id="_co_idm139784367475488"><h3 class="no_margin">Baoxing Fan</h3><p><sup>4</sup>301 Hospital, Fuxing Road 28, Beijing, 100039 PR China </p><div>Find articles by <a href="/pubmed/?term=Fan%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Baoxing Fan</a></div></div><div id="_co_idm139784374512592"><h3 class="no_margin">Shengyong Huang</h3><p><sup>1</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Airport industry B6, Beijing, 101300 PR China </p><div>Find articles by <a href="/pubmed/?term=Huang%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Shengyong Huang</a></div></div><div id="_co_idm139784373073280"><h3 class="no_margin">Yan Qiu</h3><p><sup>5</sup>Beijing Red Cross Blood Center, North middle Sanhuan Road 37, Beijing, 100088 PR China </p><div>Find articles by <a href="/pubmed/?term=Qiu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Yan Qiu</a></div></div><div id="_co_idm139784373070912"><h3 class="no_margin">Bo You</h3><p><sup>1</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Airport industry B6, Beijing, 101300 PR China </p><div>Find articles by <a href="/pubmed/?term=You%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Bo You</a></div></div><div id="_co_idm139784367515424"><h3 class="no_margin">Weijun Chen</h3><p><sup>1</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Airport industry B6, Beijing, 101300 PR China </p><div>Find articles by <a href="/pubmed/?term=Chen%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19038059">Weijun Chen</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139784370358720_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139784370358720_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139784370358720_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139784370358720_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Beijing Institute of Genomics, Chinese Academy of Sciences, Airport industry B6, Beijing, 101300 PR China </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Millitary Medical Sciences, Dongdajie Road 20, Beijing, 100071 PR China </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>302 Hospital, Fengtai Road 26, Beijing, 100853 PR China </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>301 Hospital, Fuxing Road 28, Beijing, 100039 PR China </div><div class="fm-affl" lang="en" id="Aff5"><sup>5</sup>Beijing Red Cross Blood Center, North middle Sanhuan Road 37, Beijing, 100088 PR China </div><div><span class="fm-affl">Feng Mu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.gro.scimoneg@gnefum" class="oemail">nc.gro.scimoneg@gnefum</a></span>.</div><div><a href="#idm139784370358720aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139784370358720_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Jun 25; Accepted 2008 Nov 28.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139784370358720_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Mu et al; licensee BioMed Central Ltd. 2008</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden"></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">In the absence of effective drugs, controlling SARS relies on the rapid identification of cases and appropriate management of the close contacts, or effective vaccines for SARS. Therefore, developing specific and sensitive laboratory tests for SARS as well as effective vaccines are necessary for national authorities.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p2" class="p p-first-last">Genes encoding truncated nucleocapsid (N) and spike (S) proteins of <em>SARSCoV</em> were cloned into the expression vector <em>pQE30</em> and fusionally expressed in <em>Escherichia coli</em> M15. The fusion protein was analyzed for reactivity with SARS patients\' sera and with anti-sera against the two human coronaviruses <em>HCoV</em> 229E and <em>HCoV</em> OC43 by ELISA, IFA and immunoblot assays. Furthermore, to evaluate the antigen-specific humoral antibody and T-cell responses in mice, the fusion protein was injected into 6-week-old BALB/c mice and a neutralization test as well as a T-cell analysis was performed. To evaluate the antiviral efficacy of immunization, BALB/c mice were challenged intranasally with <em>SARSCoV</em> at day 33 post injection and viral loads were determined by fluorescent quantitative RT-PCR. Serological results showed that the diagnostic sensitivity and specificity of the truncated S-N fusion protein derived the SARS virus were &#x0003e; 99% (457/460) and 100.00% (650/650), respectively. Furthermore there was no cross-reactivity with other two human coronaviruses. High titers of antibodies to <em>SRASCoV</em> appeared in the immunized mice and the neutralization test showed that antibodies to the fusion protein could inhibit <em>SARSCoV</em>. The T cell proliferation showed that the fusion protein could induce an antigen-specific T-cell response. Fluorescent quantitative RT-PCR showed that BALB/c mice challenged intranasally with <em>SARSCoV</em> at day 33 post injection were completely protected from virus replication.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Conclusion</h3><p id="__p3" class="p p-first-last">The truncated S-N fusion protein is a suitable immunodiagnostic antigen and vaccine candidate.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Electronic supplementary material</h3><p id="__p4" class="p p-first-last">The online version of this article (doi:10.1186/1471-2180-8-207) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Fusion Protein, Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome, Indirect Immunofluorescence Assay, Severe Acute Respiratory Syndrome Patient</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">The epidemic of severe atypical pneumonia, designated "severe acute respiratory syndrome (SARS)" by the World Health Organization (WHO) and first observed in Guangdong Province of China in November 2002, affected 8422 people and caused 916 deaths in 33 countries and areas worldwide up to August 7, 2003 [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode">2</a>]. A novel coronavirus, SARS-associated coronavirus (<em>SARSCoV</em>), was confirmed as the pathogen [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060280">3</a>&#x02013;<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060283">6</a>]. In the absence of effective drugs, controlling this disease relies on the rapid identification of cases and appropriate management of the close contacts, or effective vaccines against SARS. Therefore, the development of both specific and sensitive laboratory tests for SARS as well as effective vaccines is necessary for national authorities.</p><p id="__p6">Laboratory tests for SARS based on indirect immunofluorescence assay (IFA) or viral particle lysate enzyme-linked immunosorbent assay (<em>SARSCoV</em> lysate ELISA) to detect antibodies against <em>SARSCoV</em> are important methods [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060286">7</a>]. However, these methods both require cultivation of <em>SARSCoV</em> in a biosafety level 3 or 4 laboratory, which is both dangerous and difficult. Finding a suitable diagnostic test for this virus therefore remains a high priority. A practical approach towards this goal is to clone and express the immunodominant genes of <em>SARSCoV</em>.</p><p id="__p7" class="p p-last">Several studies have shown that most of the antigenic epitopes of <em>SARSCoV</em> are located on the nucleocapsid (N) and spike (S) proteins and that the latter protein has an important role in viral entry and pathogenesis [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060290">8</a>&#x02013;<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060272">12</a>]. Other data have shown that the viral N and S proteins of coronaviruses could induce a specific T cell response [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060285">13</a>&#x02013;<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060277">16</a>]. Here, we report the cloning and expression of a truncated S-N fusion protein of <em>SARSCoV</em> and the investigation of its antigenicity and immunogenicity.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Viruses and vectors</h3><p id="__p8" class="p p-first-last">The <em>pQE30</em> vector was purchased from Qiagen (Qiagen GmbH, Hilden, Germany). <em>Escherichia coli</em> M15 was used as host strain for <em>the</em> vector. The following virus strains were kindly provided by the Academy of Military Medical Science and the National Institute for the Control of Pharmaceutical and Biological Products: The <em>SARSCoV</em> (BJ01); <em>SARSCoV</em> (GD01); human coronavirus 229E (<em>HCoV</em> 229E) and human coronavirus OC43 (<em>HCoV</em> OC43). All work with infectious virus was performed in a biosafety level 3 laboratory.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Construction of recombinant expression plasmids</h3><p id="__p9" class="p p-first-last">Viral RNA was extracted with TRIzol according to manual (Invitrogen). All primers were synthesized by the Shanghai Sangon Company according to the published DNA sequences (table <a href="/pmc/articles/PMC2613400/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(table1).</span></span><span>1</span></a>). Genomic <em>SARSCoV</em> sequences for N protein as well as for truncated N (321-422aa) and S (264-680aa) proteins were amplified by RT-PCR in a mixture of 200 &#x003bc;M (each) deoxynucleoside triphosphate, 0.3 &#x003bc;M (each) primer, 1 U of <em>Taq</em> polymerase (Takara) in 10 mM Tris-HCl buffer (pH 8.3) supplemented with 2.0 mM MgCl<sub>2</sub> and 50 mM KCl. The PCR reactions were started with 10 min at 95&#x000b0;C and followed by 35 cycles, with 1 cycle consisting of 45 sec at 94&#x000b0;C, 30 sec at 55&#x000b0;C, and 60 sec at 72&#x000b0;C. A final step of 5 min at 72&#x000b0;C was added to the last cycle. The fusion gene construct was established for expression of a truncated S-N fusion protein. The recombinant plasmids were constructed as described elsewhere [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844967796">17</a>]. All restriction enzymes and ligases were purchased from TaKaRa biotechnology Co., Ltd (Dalian, China). <em>E. coli</em> M15 was transformed with ligation mixtures and the control vector, respectively. The presence of the target genes in the recombinant plasmids was verified by gene-specific PCR and sequence analysis.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p10">Primers used for target gene by RT-PCR</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784415066080" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Primer<sup>a</sup></th><th align="center" rowspan="1" colspan="1">Primer sequences<sup>b</sup></th><th align="center" rowspan="1" colspan="1">PCR product (bp)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SARS-Nf-4</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggatcc</span></em> tct gat aat gga ccc ca -3\'</td><td align="center" rowspan="1" colspan="1">1266</td></tr><tr><td align="left" rowspan="1" colspan="1">SARS-Nr-1269</td><td align="center" rowspan="1" colspan="1">5\'- gc <em><span class="underline">ctgcag</span></em> tta tgc ctg agt tga atc agc aga -3\'</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">229E-Nf-4</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggatcc</span></em> gct aca gtc aaa tgg gct gat -3\'</td><td align="center" rowspan="1" colspan="1">1167</td></tr><tr><td align="left" rowspan="1" colspan="1">229E-Nr-1170</td><td align="center" rowspan="1" colspan="1">5\'- ccc <em><span class="underline">gtcgac</span></em> tta gtt tac ttc atc aat tat -3\'</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">OC43-Nf-4</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggatcc</span></em> tct ttt act cct ggt aag caa -3\'</td><td align="center" rowspan="1" colspan="1">1344</td></tr><tr><td align="left" rowspan="1" colspan="1">OC43-Nr-1347</td><td align="center" rowspan="1" colspan="1">5\'- ccc <em><span class="underline">aagctt</span></em> tta tat ttc tga ggt gtc ttc -3\'</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">SARS-tNf-961</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggtacc</span></em> att ggc atg gaa gtc aca -3\'</td><td align="center" rowspan="1" colspan="1">309</td></tr><tr><td align="left" rowspan="1" colspan="1">SARS-tNr-1269</td><td align="center" rowspan="1" colspan="1">5\'- ccc <em><span class="underline">ctgcag</span></em> tta tgc ctg agt tga atc agc aga -3\'</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">229E-tNf-925</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggatcc</span></em> gtt tcc aaa gag tca ggc aac -3\'</td><td align="center" rowspan="1" colspan="1">246</td></tr><tr><td align="left" rowspan="1" colspan="1">229E-tNr-1170</td><td align="center" rowspan="1" colspan="1">5\'- ccc <em><span class="underline">gtcgac</span></em> tta gtt tac ttc atc aat tat -3\'</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">OC43-tNf-985</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggatcc</span></em> tta gag ttg gcc aaa gtg -3\'</td><td align="center" rowspan="1" colspan="1">363</td></tr><tr><td align="left" rowspan="1" colspan="1">OC43-tNr-1347</td><td align="center" rowspan="1" colspan="1">5\'- ccc <em><span class="underline">aagctt</span></em> tta tat ttc tga ggt gtc ttc -3\'</td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">SARS-tSf-790</td><td align="center" rowspan="1" colspan="1">5\'- cgc <em><span class="underline">ggatcc</span></em> ctc aag tat gat gaa aat ggt aca atc aca -3\'</td><td align="center" rowspan="1" colspan="1">1251</td></tr><tr><td align="left" rowspan="1" colspan="1">SARS-tSr-2040</td><td align="center" rowspan="1" colspan="1">5\'- gc <em><span class="underline">ggtacc</span></em> aga cat agt ata agc cac aat aga -3\'</td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm139784415066080" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p11"><sup>a</sup> f and r signify forward and reverse primers, respectively.</p><p id="__p12"><sup>b</sup> underlined sequences indicate restriction sites: <em>Bam</em> HI (ggatcc), <em>Pst</em> I (ctgcag), <em>Sal</em> I (gtcgac), <em>Hin</em> dIII (aagctt), and <em>Kpn</em> I (ggtacc).</p></div></div></div><div id="Sec5" class="sec"><h3 id="Sec5title">Expression and purification of the recombinant proteins</h3><p id="__p13" class="p p-first">The materials and methods used for obtaining the recombinant proteins were described in detail elsewhere [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844967797">17</a>]. The transformed bacteria were induced with 2.0 mM IPTG at 37&#x000b0;C and inclusion bodies containing recombinant proteins with N-terminal sequences of six consecutive His residues were serially extracted with 2 M urea and then dissolved in 8 M urea. It was then subjected to purification by means of a Ni-NTA Affinity Chromatography Purification Kit according to manual (Qiagen GmbH). Recovery of purified and renatured recombinant proteins from the denatured state in 8 M urea in buffer A (10 mM Tris-Cl (pH 7.0), 100 mM NaH<sub>2</sub>PO<sub>4</sub>) was achieved by sequential dialysis against 6 M, 4 M and 2 M urea in buffer A and finally against buffer A only. In detail, the products were dialyzed twice against 5 volumes of 6 M urea in buffer A for 30 min at room temperature. The same procedure was repeated with 4 M urea and 2 M urea in buffer A. The final dialysis was against buffer A with two initial changes of buffer after 30 min each and a final dialysis overnight at 4&#x000b0;C. The purity of the target proteins was determined by SDS-PAGE [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060276">18</a>], see Figure <a href="/pmc/articles/PMC2613400/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1</span></span><span>1</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2613400/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784366597776" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig1_HTML.jpg" src="/pmc/articles/PMC2613400/bin/12866_2008_Article_640_Fig1_HTML.jpg" /></div><div id="largeobj_idm139784366597776" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2613400/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p14"><strong>SDS-PAGE analysis of the expression and purification target proteins</strong>. Lane 1: purified <em>HCoV</em> 229E truncated N protein; Lane 2: purified <em>SARSCoV</em> truncated N protein; Lane 3: purified <em>HCoV</em> OC43 truncated N protein; Lane 4: purified <em>HCoV</em> 229E N protein; Lane 5: purified <em>SARSCoV</em> N protein; Lane 6: purified <em>HCoV</em> OC43 N protein; Lane 7: purified <em>SARSCoV</em> truncated S-N fusion protein; Lane 8: purified <em>SARSCoV</em> truncated S protein; Lane M: protein molecular weight marker.</p></div></div></div><div id="Sec6" class="sec"><p></p><h4 id="Sec6title" class="inline">Human sera </h4><p id="__p15" class="p p-first-last">SARS patients\' sera: 460 serum samples from SARS convalescents (from 35 to 114 days after the onset of illness) fulfilling the clinical WHO case definition of SARS, and whose diagnosis was subsequently confirmed by seroconversion, were collected in 301 Hospital (Beijing, China) and 302 Hospital (Beijing, China). All sera were tested positive by the <em>SARSCoV</em> lysate ELISA IgG Kit (Beijing BGI-GBI Biotech Corp.), which has been approved by the State Food and Drug Administration (SFDA) for the detection of anti-<em>SARSCoV</em> immunoglobulin (Ig) G antibody from human serum or plasma specimens.</p></div><div id="Sec7" class="sec"><p></p><h4 id="Sec7title" class="inline">Control sera </h4><p id="__p16" class="p p-first-last">Sera from 650 Healthy blood donors were collected by the Beijing Red Cross blood center from May to October 2003.</p></div><div id="Sec8" class="sec sec-last"><p></p><h4 id="Sec8title" class="inline">Mouse Sera </h4><p id="__p17" class="p p-first-last">Polyclonal mouse sera against <em>SARSCoV</em> (BJ01), <em>HCoV</em> 229E and <em>HCoV</em> OC43 were prepared in our laboratory (IFA dilution: 1:5120, 1:5120, 1:10240, respectively) as were polyclonal mouse sera against purified recombinant proteins <em>SARSCoV</em> N, <em>HCoV</em> OC43 N, <em>HCoV</em> 229E N (IFA dilution: 1:5120, 1:2560, 1:5120, respectively). Control sera were collected from healthy BALB/c mice.</p></div></div><div id="Sec9" class="sec"><h3 id="Sec9title">Immunization</h3><p id="__p18" class="p p-first-last">Mouse immunization was performed according to established protocols [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]. Briefly, sixteen 6-week-old BALB/c mice were divided into 2 groups and injected subcutaneously with 0.1 mL of purified recombinant fusion truncated S-N protein solution (100 &#x003bc;g/mL) and PBS, respectively, both mixed with an equal volume of paraffin oil. Immunized mice were boosted after 24 days using the half dose of antigen by celiac arterial route.</p></div><div id="Sec10" class="sec"><h3 id="Sec10title">Immunological analyses</h3><div id="Sec11" class="sec sec-first"><p></p><h4 id="Sec11title" class="inline">Immunoblot analysis </h4><p id="__p19" class="p p-first-last">An immunoblot analysis was performed as described in detail elsewhere [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060287">18</a>]. SDS-PAGE analysis was performed using the Mini-protein 3 Electrophoresis System (BIO-RAD). The stacking gel and separation gel contained 5% and 15% acrylamide, respectively. Electrophoresis was carried out at a constant voltage of 120 V for 180 min. The proteins were electroblotted onto nitrocellulose membranes. The mouse sera were then tested against each of the recombinant proteins.</p></div><div id="Sec12" class="sec"><p></p><h4 id="Sec12title" class="inline">IFA </h4><p id="__p20" class="p p-first-last">An indirect immunofluorescence assay (IFA) was performed to detect antibodies to <em>SARSCoV</em> (BJ01), <em>HCoV</em> 229E and <em>HCoV</em> OC43 by using <em>SARSCoV</em> according to established protocols [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>].</p></div><div id="Sec13" class="sec"><p></p><h4 id="Sec13title" class="inline">ELISA </h4><p id="__p21" class="p p-first-last">Microtiter plates (96 wells, Shenzhen Jinchanhua Co. Ltd) were coated overnight at 4&#x000b0;C with either of the eight recombinant antigens (four recombinant antigens of <em>SARSCoV</em>: truncated S protein, N protein, truncated N protein, and truncated S-N fusion protein; two recombinant antigens of <em>HCoV</em> 229E: truncated N protein, N protein; two recombinant antigens of <em>HCoV</em> OC43: truncated N protein, N protein) diluted in 50 mM NaHCO<sub>3</sub> buffer (pH 9.6). Each well was rinsed with PBS (phosphate-buffered saline) containing 0.05% Tween-20 and 3% BSA for blocking the remaining protein-binding sites. After incubation at 37&#x000b0;C for 1 hour, the plates were washed five times with the PBS/Tween-20 buffer. Diluted serum samples (1:10 with PBS) were added to the plates. The plates were incubated at 37&#x000b0;C for 30 min and washed five times with the PBS/Tween-20 buffer. After addition of peroxidase-conjugated goat anti-human IgG (diluted 1:2000 in PBS supplemented with 0.5% of Tween-20 and 1.5% of BSA) to each well and the plates were incubated at 37&#x000b0;C for 30 min, then washed five times with the PBS/Tween-20 buffer before the addition of tetramethyl-benzidine (TMB)/hydrogen peroxide substrate. Reaction was stopped by addition of 2 M H<sub>2</sub>SO<sub>4</sub>. The OD<sub>450/630</sub> value was measured with a microtiter plate reader in triplicates. A blank control, a negative control and a positive control were always included on each plate. The cut-off values for IgG were 0.16 (three N proteins), 0.12 (truncated S protein), 0.14 (three truncated N proteins), 0.12 (truncated S-N protein), respectively, which were calculated as the mean + 2 SD of the readings given by 1000 blood donor control sera collected from 2001 to 2002 in Beijing. Samples were tested again in triplicates when their OD<sub>450/630</sub> values were near the cut-off values. For the detection of mice antibodies, all procedures were the same as for detection of human antibodies except that peroxidase-conjugated goat anti-mice IgG diluted to 1:1000 was used. Mice sera were diluted to 1:20 with PBS.</p></div><div id="Sec14" class="sec"><p></p><h4 id="Sec14title" class="inline">Neutralization test </h4><p id="__p22" class="p p-first-last">Neutralizing titer (NT) of mouse sera was measured by a rapid microneutralization assay [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060279">21</a>]. In brief, heat-inactivated (55&#x000b0;C for 30 min) mouse immune serum was diluted tenfold and then serially diluted twofold to 1:2560 in DMEM (Gibco) containing 5% heat-inactivated fetal calf serum (56&#x000b0;C for 30 min). Approximately 50 &#x003bc;L of <em>SARSCoV</em> (BJ01 strain) (400 TCID<sub>50</sub>/100 &#x003bc;L) was mixed with an equal volume of diluted serum and incubated at 35&#x000b0;C for 1 h; then 50 uL of the mixture (containing 100 TCID<sub>50</sub>) and 50 &#x003bc;L of DMEM containing 5% inactivated fetal calf serum were added onto a VeroE6 cell monolayer in triplicate. The viral cytopathic effect (CPE) was observed on days 2 and 3. The dilution of serum that completely prevented CPE in 50% of the wells was calculated according to the Reed Muench formula [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>].</p></div><div id="Sec15" class="sec sec-last"><p></p><h4 id="Sec15title" class="inline">Cross-reactivity among viruses and recombinant proteins </h4><p id="__p23" class="p p-first-last">Serological cross-reactivity among different human coronaviruses was tested by incubation of <em>SARSCoV</em>-infected cells with mouse antisera against the two other human coronaviruses, <em>HCoV</em> 229E and <em>HCoV</em> OC43, and subsequent indirect immunofluorescence assay (IFA). To evaluate cross-reactivity among different recombinant proteins of the three human coronaviruses, the proteins were subjected to immunoblot assays with mouse antisera against the proteins as well as antisera against the viruses and were also subjected to ELISA with 460 serum samples from SARS convalescents as well as mice antisera against the viruses.</p></div></div><div id="Sec16" class="sec"><h3 id="Sec16title">Immune responses to the truncated <em>SARSCoV</em> S-N fusion protein</h3><div id="Sec17" class="sec sec-first"><p></p><h4 id="Sec17title" class="inline">Humoral immune response </h4><p id="__p24" class="p p-first-last">Serum samples were collected from the tail veins every 3 days after the initial immunization and the final serum samples were collected from the orbital plexus for antibody level assessment by the <em>SARSCoV</em> lysate ELISA IgG Kit according to the manufacturer\'s instruction, except that peroxidase-conjugated goat anti-human IgG was substituted by peroxidase-conjugated goat anti-mouse IgG (Sihuan Sci-Technics Company, Beijing). A value of S/N &#x02265; 2.1 was taken as positive standard.</p></div><div id="Sec18" class="sec sec-last"><p></p><h4 id="Sec18title" class="inline">Spleen lymphocyte immune response </h4><p id="__p25" class="p p-first-last">The proliferation of spleen lymphocytes was measured by colorimetric analysis described previously [<a href="#CR23" rid="CR23" class=" bibr popnode">23</a>]. Four BALB/c mice in each group were killed on day 33 after immunization and their spleens were ground into single-cell suspensions in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum. The suspensions were mixed with 5 volumes of erythrocyte lysis buffer (0.01 M Tris-HCl pH 7.6; 0.01 M NaCl; 0.005 M MgCl<sub>2</sub>), incubated for 10 minutes on ice and centrifuged at 400 g for 5 min at 4&#x000b0;C. The pellets were resuspended in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum. They were seeded in triplicates in flat-bottom 96-well microtiter plates (Costar) with 5 &#x000d7; 10<sup>5</sup> cells per well in 100 &#x003bc;L of culture medium with purified and truncated S-N protein at 10, 3, 1, 0.3 and 0 &#x003bc;g/mL, respectively. After incubation for 3 days with 5% CO<sub>2</sub> at 37&#x000b0;C, 10 &#x003bc;L of a solution of the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each well, and the plates were incubated for 4 h at 37&#x000b0;C. One hundred microliter of lysis buffer containing 10% Triton-50% isopropanol-0.01 M hydrochloric acid was then added to each well, and the plates were incubated overnight. The optical densities at 570 nm (OD<sub>570</sub>) and at 630 nm (OD<sub>630</sub>) were measured.</p></div></div><div id="Sec19" class="sec sec-last"><h3 id="Sec19title"><em>SARSCoV</em> challenge and determination of virus load</h3><p id="__p26" class="p p-first">Four BALB/c mice from each group, immunized as well as controls, were challenged intranasally with 10<sup>4</sup> TCID<sub>50</sub> of the <em>SARSCoV</em> GD01 strain on day 33 after immunization to tested the heterologous protection. After two days of clinical observation the mice were sacrificed and their lungs were collected for determination of the level of viral RNA.</p><p id="__p27" class="p p-last">Fifty mg lung tissue was first homogenized in liquid nitrogen and then in 1 mL of TRIzol. Tissue homogenates were clarified by low-speed centrifugation (3000 rpm). RNA extraction was performed according to manual (Invitrogen). Virus loads were determined by fluorescent quantitative RT-PCR and expressed as number of copies per gram tissue [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845472358">24</a>].</p></div></div><div id="Sec20" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec20title">Results</h2><div id="Sec21" class="sec sec-first"><h3 id="Sec21title">Serological cross-reactivity among coronaviruses and recombinant proteins</h3><p id="__p28" class="p p-first-last">The result of immunofluorescence analysis of cross-reactivity between <em>SARSCoV</em>-infected cells and mouse antisera against each N protein of the three coronaviruses is shown in Figure <a href="/pmc/articles/PMC2613400/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2.</span></span><span>2</span></a>. The results show that mouse anti-sera to <em>HCoV</em> 229E N protein and <em>HCoV</em> OC43 N protein cross-react with <em>SARSCoV</em>. Figure <a href="/pmc/articles/PMC2613400/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3</span></span><span>3</span></a> shows the result of immunoblot analyses for cross-reactions between (i) intact N protein from the three human coronaviruses plus the truncated S protein and mouse antisera against each coronavirus (panels A, B, and C) and (ii) truncated N protein from each coronavirus and mouse antisera against each coronavirus (panels D, E and F). The results showed (a) cross-reactions between the intact N proteins and the antisera against the three coronaviruses and (b) no cross-reaction between the antisera and the truncated proteins. The recombinant proteins of <em>HCoV</em> 229E and <em>HCoV</em> OC43 were also tested with 460 serum samples from SARS convalescents by ELISA. The results showed 34 and 21 sera were tested positive by N proteins of <em>HCoV</em> OC43 and <em>HCoV</em> 229E respectively, while none of the sera were tested positive by both truncated N proteins of <em>HCoV</em> OC43 and <em>HCoV</em> 229E.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2613400/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784415120112" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig2_HTML.jpg" src="/pmc/articles/PMC2613400/bin/12866_2008_Article_640_Fig2_HTML.jpg" /></div><div id="largeobj_idm139784415120112" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2613400/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p29"><strong>IFA analysis of cross-reaction of the</strong>\n<strong><em>SARSCoV</em></strong>\n<strong>infected cell using mouse anti-sera to recombinant N proteins of other two human Coronaviruses</strong>. A: Reacted with mouse anti-serum to <em>SARSCoV</em> N protein; B: Reacted with mouse anti-serum to <em>HCoV</em> 229E N protein; C: Reacted with mouse anti-serum to <em>HCoV</em> OC43 N protein; D: Reacted with mouse serum from controls injected with PBS;</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2613400/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784374883296" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig3_HTML.jpg" src="/pmc/articles/PMC2613400/bin/12866_2008_Article_640_Fig3_HTML.jpg" /></div><div id="largeobj_idm139784374883296" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2613400/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p30"><strong>Immunoblot assay analysis of cross-reaction of the coronaviruses recombinant proteins using mouse anti-sera to three different human Coronaviruses and recombinant proteins</strong>. A: Reacted with mouse anti-serum to <em>HCoV229E</em>; B: Reacted with mouse anti-serum to <em>SARSCoV</em>; C: Reacted with mouse anti-serum to <em>HCoVOC43</em>; Lane 1: Purified <em>HCoV229E</em> N protein; Lane 2: Purified <em>HCoVOC43</em> N protein; Lane 3: Purified <em>SARSCoV</em> N protein; Lane 4: Purified <em>SARSCoV</em> truncated S protein; D: Reacted with mouse anti-serum to <em>SARSCoV</em>; E: Reacted with mouse anti-serum to <em>HCoV229E</em>; F: Reacted with mouse anti-serum to <em>HCoVOC43</em>; Lane 5: Purified <em>SARSCoV</em> truncated N protein; Lane 6: Purified <em>HCoV229E</em> truncated N protein; Lane 7: Purified <em>HCoVOC43</em> truncated N protein.</p></div></div></div></div><div id="Sec22" class="sec"><h3 id="Sec22title">Diagnostic sensitivity and specificity of ELISA with truncated S-N fusion protein as antigen</h3><p id="__p31" class="p p-first-last">The qualities of truncated S protein, N protein, truncated N protein and truncated S-N fusion protein as diagnostic antigens were evaluated by ELISA technique as described in Materials and Methods. All 460 SARS patients\' sera were tested against all four antigens. Only 3 samples were tested negative in the truncated S-N fusion protein assay, whereas 62, 38 and 43 samples were tested negative in the truncated S protein, N protein and truncated N protein assays, respectively (Table <a href="/pmc/articles/PMC2613400/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). Compared with <em>SARSCoV</em> lysate ELISA, the sensitivity of ELISA with truncated S protein, N protein, truncated N protein and truncated S-N fusion protein as antigens were 86.5% (398/460), 91.7% (422/460), 90.7% (417/460) and &#x0003e; 99% (457/460), respectively. To evaluate the specificity of these assays, the sera of the 650 healthy people were tested. Only a few gave a positive reaction with either <em>SARSCoV</em> lysate or N protein, whereas none reacted against the truncated proteins (Table <a href="/pmc/articles/PMC2613400/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). To further evaluate the specificity of the truncated S-N fusion protein, the polyclonal mouse sera against <em>SARSCoV</em> (BJ01), <em>HCoV</em> 229E and <em>HCoV</em> OC43 antisera to were tested by ELISA. Only mice antiserum against <em>SARSCoV</em>(BJ01) tests positive.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p32">Antibody detection rates for recombinant protein ELISA and <em>SARSCoV</em> lysate ELISA of sera from SARS patients and healthy controls.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784379269632" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">Coating antigen</th><th align="center" colspan="2" rowspan="1">Sera of SARS patients</th><th align="center" colspan="2" rowspan="1">Sera of healthy blood donors</th></tr><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Positive</th><th align="center" rowspan="1" colspan="1">negative</th><th align="center" rowspan="1" colspan="1">Positive</th><th align="center" rowspan="1" colspan="1">negative</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><em>SARSCoV</em> lysate</td><td align="center" rowspan="1" colspan="1">460</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">645</td></tr><tr><td align="center" rowspan="1" colspan="1">truncated S protein</td><td align="center" rowspan="1" colspan="1">398</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">650</td></tr><tr><td align="center" rowspan="1" colspan="1">N protein</td><td align="center" rowspan="1" colspan="1">422</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">642</td></tr><tr><td align="center" rowspan="1" colspan="1">truncated N protein</td><td align="center" rowspan="1" colspan="1">417</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">650</td></tr><tr><td align="center" rowspan="1" colspan="1">truncated S-N protein</td><td align="center" rowspan="1" colspan="1">457</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">650</td></tr></tbody></table></div><div id="largeobj_idm139784379269632" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/table/Tab2/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec23" class="sec"><h3 id="Sec23title">Specific humoral and cellular anti- <em>SARSCoV</em> immune responses to the truncated S-N fusion protein</h3><p id="__p33" class="p p-first">Sera antibody tests showed the ability of the fusion protein to induce the generation of SARS-specific antibodies in the immunized mice. Nine to twelve days after injection, the specific Ig G antibody could be detected. To test whether the mouse sera against the truncated S-N protein were able to neutralize <em>SARSCoV</em>, a property that is likely to be crucial in the defense against virus infection, the <em>SARSCoV</em> BJ01 strain was used in a microneutralization assay as described in Materials and Methods. The serum titer of neutralizing antibodies against <em>SARSCoV</em> was 2.425 &#x000b1; 0.209 (Lg dilution &#x000b1; SD)</p><p id="__p34" class="p p-last">The lymphocytes proliferation assay showed that the truncated S-N protein could induce T cell proliferation of mice immunized with the truncated fusion protein (Table <a href="/pmc/articles/PMC2613400/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3).</span></span><span>3</span></a>). There are significant differences between mice immunized with the truncated fusion protein and the controls (t test <em>p</em> = 0.0084 &#x0003c; 0.05).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p35">Effects of recombinant protein on spleen cell proliferation in mice injected with recombinant proteins and a control group of mice injected with PBS by MTT<sup>a</sup></p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784370896144" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" colspan="5" rowspan="1">Proliferation (D value<sup>b</sup> &#x000b1; SD) with the following concentration (&#x003bc;g/ml) of recombinant proteins</th></tr><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">10</th><th align="center" rowspan="1" colspan="1">3</th><th align="center" rowspan="1" colspan="1">1</th><th align="center" rowspan="1" colspan="1">0.3</th><th align="center" rowspan="1" colspan="1">0</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PBS Control</td><td align="center" rowspan="1" colspan="1">0.116 &#x000b1; 0.112</td><td align="center" rowspan="1" colspan="1">0.074 &#x000b1; 0.046</td><td align="center" rowspan="1" colspan="1">0.011 &#x000b1; 0.002</td><td align="center" rowspan="1" colspan="1">0.022 &#x000b1; 0.008</td><td align="center" rowspan="1" colspan="1">0.043 &#x000b1; 0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">truncated S-N</td><td align="center" rowspan="1" colspan="1">0.603 &#x000b1; 0.118</td><td align="center" rowspan="1" colspan="1">0.551 &#x000b1; 0.019</td><td align="center" rowspan="1" colspan="1">0.542 &#x000b1; 0.216</td><td align="center" rowspan="1" colspan="1">0.476 &#x000b1; 0.274</td><td align="center" rowspan="1" colspan="1">0.068 &#x000b1; 0.021</td></tr></tbody></table></div><div id="largeobj_idm139784370896144" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/table/Tab3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p36"><sup>a</sup> Four BALB/c mice of each group were killed. Spleens were harvested and lymphocyte cultures (Three repeats) were stimulated in vitro for 3 days with medium or with various concentrations of purified recombinant fusion truncated S-N protein (three repeats). The truncated S-N protein could induce T cell proliferation and significant differences were found between the groups of mice immunized with recombinant protein or injected with PBS (T test P = 0.0084 &#x0003c; 0.05).</p><p id="__p37"><sup>b</sup> D Value = D<sub>570</sub>-D<sub>630</sub>-blank</p></div></div></div><div id="Sec24" class="sec sec-last"><h3 id="Sec24title">Protection from <em>SARSCoV</em> challenge and virus replication</h3><p id="__p38" class="p p-first-last">No clinical signs of illness were observed in either group of SARS-challenged mice. The analysis for <em>SARSCoV</em> genome copies in the lungs of immunized mice and controls was performed. The mean of virus genome copy numbers are 20708 &#x000b1; 6202 (copies/g &#x000b1; SD) per 1 gram lung tissue in the control group, whereas virus loads in mice immunized with truncated S-N protein were below the limit of detection.</p></div></div><div id="Sec25" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec25title">Discussion</h2><p id="__p39" class="p p-first">SARS, a newly emerged infectious disease which caused worldwide outbreak in 2003, has been a crucial public health problem. Establishing specific and convenient laboratory tests for SARS and finding a vaccine for this virus are of high priority.</p><p id="__p40">Previous data have shown a high degree of sequence similarity between the nucleocapsid (N) proteins of coronaviruses and demonstrated serious serological cross-reactions [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060281">25</a>, <a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060278">26</a>]. We aligned the N protein of five human coronaviruses (<em>SARSCoV</em>, <em>HCoV</em> 229E, <em>HCoV</em> NL63, <em>HCoV</em> OC43 and <em>HCoV</em> HKU1) and found several fairly homologous regions, e.g. <em>SARSCoV</em> 57-210aa, 258-320aa. In these regions, the N protein of <em>SARSCoV</em> is 35&#x02013;39% identical in amino acid sequence to the N protein of <em>HCoV</em> 229E and <em>HCoV</em> NL63 and 47&#x02013;50% identical in amino acid sequence to that of <em>HCoV</em> OC43 and <em>HCoV</em> HKU1 (Figure <a href="/pmc/articles/PMC2613400/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4).</span></span><span>4</span></a>). We also found that the C-terminal of the N protein (<em>SARSCoV</em> 321-422aa) has lower identity in amino acid sequence among these human coronaviruse (Figure <a href="/pmc/articles/PMC2613400/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4).</span></span><span>4</span></a>). In addition, our previous research showed that some unique highly antigenic sites are located in the C-terminal part of the SARS N protein and in the 270-667aa of the SARS spike (S) protein [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060268">8</a>]. Other research also showed that the C-terminal part of the SARS N protein was highly antigenic [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060273">27</a>]. In the present study, using the <em>pQE30</em> expression vector we cloned the N genes, gene segments encoding the C-terminal parts of the N proteins from all three coronaviruses, as well as <em>SARSCoV</em> gene segments encoding a truncated spike protein (264-680 aa) and a truncated S-N fusion protein, respectively. All proteins were highly expressed in <em>E. coli</em> M15. To evaluate the cross-reactivity of these recombinant proteins and viruses, IFA and immunoblot assays were performed. The results (Figures <a href="/pmc/articles/PMC2613400/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -4em;">(Figures2</span></span><span>2</span></a> and <a href="/pmc/articles/PMC2613400/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and3)</span></span><span>3</span></a>) showed that the truncated proteins only reacted with species-specific antiserum while the N proteins cross-reacted as did the viruses. The further ELISA results also showed that the intact N proteins of <em>HCoV</em> 229E and <em>HCoV</em> OC43 cross-reacted with SARS patients\' sera (21/460, 34/460 respectively) while the truncated N proteins did not cross-react with SARS patients\' sera.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC2613400/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139784414822176" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12866_2008_Article_640_Fig4_HTML.jpg" src="/pmc/articles/PMC2613400/bin/12866_2008_Article_640_Fig4_HTML.jpg" /></div><div id="largeobj_idm139784414822176" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2613400/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC2613400/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p41">\n<strong>Sequence alignments of N proteins of</strong>\n<strong><em>SARSCoV</em></strong>\n<strong>,</strong>\n<strong><em>HCoV</em></strong>\n<strong>229E,</strong>\n<strong><em>HCoV</em></strong>\n<strong>NL63,</strong>\n<strong><em>HCoV</em></strong>\n<strong>OC43 and</strong>\n<strong><em>HCoV</em></strong>\n<strong>HKU1 by Clustal V Method with MegAlign.</strong>\n</p></div></div></div><p id="__p42">Using the purified proteins as antigens in ELISA assays for antibodies in the sera of SARS patients we found that the assay using truncated S-N fusion protein has a clearly higher sensitivity than those using intact N protein or truncated S and N proteins, and virtually as high as the assay using whole <em>SARSCoV</em> lysate (Table <a href="/pmc/articles/PMC2613400/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). The results indicated the N and S protein were complementary in detecting SARS-specific antibodies. This is consistent with previous studies [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060284">28</a>, <a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060274">29</a>]. Five positive sera to <em>SARSCoV</em> lysate antigen were all tested positive against <em>SARSCoV</em> N protein but negative against <em>SARSCoV</em> truncated N-S protein. These sera were also tested positive against N proteins of <em>HCoV</em> 229E and <em>HCoV</em> OC43 (data not shown), which could be reasonably explained partly by existence of other <em>HCoV</em> infections in these humans. The truncated S-N fusion protein was also subjected to ELISA with mice antisera against <em>SARSCoV</em> (BJ01), <em>HCoV</em> 229E and <em>HCoV</em> OC43. Only mice antiserum against <em>SARSCoV</em>(BJ01) tests positive. These results showed that the <em>SARSCoV</em> truncated N-S protein had high specificity. Considering the difficulty of <em>SARSCoV</em> lysate antigen production and its false positive ratio (~0.77%, Table <a href="/pmc/articles/PMC2613400/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2),</span></span><span>2</span></a>), the truncated S-N fusion protein is a suitable diagnostic antigen for detection of <em>SARSCoV</em> antibodies.</p><p id="__p43" class="p p-last">The S protein of <em>SARSCoV</em> is an important determinant of tissue tropism, as it mediates virus and cellular membrane fusion. Analysis of neutralizing epitopes showed that the receptor-binding region of the S protein plays an important role in virus infection [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060289">12</a>, <a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060282">30</a>, <a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060271">31</a>]. A DNA vaccine study of <em>SARSCoV</em> has also shown that the S protein can induce protective immune responses to <em>SARSCoV</em> [<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844967798">32</a>]. Moreover, some data showed that the N protein of <em>SARSCoV</em> could induce specific T-cell responses and studies of animal coronaviruses have suggested that both cellular and humoral immunity contribute to protection during persistent infection [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060270">13</a>, <a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060269">16</a>, <a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844060267">33</a>]. Considering that our fusion protein includes the receptor-binding region of the S protein and immunodominant T-cell epitopes of the N protein, we also investigated the role of the truncated S-N protein in anti-<em>SARSCoV</em> infection. Seven to nine days after injection of the fusion protein, the mice began to show seropositive for SARS antibodies. After the first booster, all mice generated high titer of SARS-specific antibodies and the antibodies could neutralize the <em>SARSCoV</em> infectivity. In the lymphocytes proliferation assay, the truncated S-N protein could induce T cell proliferation (Table <a href="/pmc/articles/PMC2613400/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3).</span></span><span>3</span></a>). Compared to the control group, the mice immunized with the truncated S-N protein were protected from <em>SARSCoV</em> challenge, as indicated by a lack of detectable viral RNA. Therefore, in addition to being a valuable diagnostic antigen the truncated S-N fusion protein is a potential candidate for the development of a SARS subunit vaccine.</p></div><div id="Sec26" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec26title">Conclusion</h2><p id="__p44" class="p p-first-last">The truncated S-N fusion protein has high sensitivity and specificity and it is a suitable diagnostic antigen for detection of <em>SARSCoV</em> antibodies. On the other hand, it could induce the mice generated high titer of SARS-specific neutralizing antibodies and T cell proliferation. The mice immunized with the truncated S-N protein were protected from <em>SARSCoV</em> challenge. It is also a potential candidate for the development of a SARS subunit vaccine.</p></div><div id="idm139784377059712" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139784377059712title">Acknowledgements</h2><div class="sec"><p id="__p55">We thank Drs. Xiuqing Zhang critical reading of the manuscript. We thank research funding from the National High Technology Research and Development Program of China (863 Program) 2003AA208216 from Ministry of Science and Technology, the People\'s Republic of China and from Chinese Academy of Sciences.</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec27" class="sec sec-first"><h3 id="Sec27title">Authors&#x02019; original submitted files for images</h3><p id="__p45" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC2613400/bin/12866_2008_640_MOESM1_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(1.8M, tiff)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2613400/bin/12866_2008_640_MOESM2_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(2.0M, tiff)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC2613400/bin/12866_2008_640_MOESM3_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(540K, tiff)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC2613400/bin/12866_2008_640_MOESM4_ESM.tiff" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(978K, tiff)</sup></span></p></div></div><div id="idm139784411542112" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139784411542112title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139784411541984"><p id="__p50" class="p p-first-last">Feng Mu, Dongsheng Niu, Jingsong Mu contributed equally to this work.</p></p><p class="fn sec" id="idm139784411541360"><p id="__p51" class="p p-first"><strong>Competing interests</strong></p><p id="__p52" class="p p-last">The authors declare that they have no competing interests.</p></p><p class="fn sec" id="idm139784411540112"><p id="__p53" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p54" class="p p-last">FM carried out the genes cloning and protein expression and drafted the manuscript. DSN carried out the Viruses challenge assays and partial immunoassays. JSM carried out clinical samples collection and partial immunoassays. BH, WGH, SYH and BY participated in the samples detection. BXF and YQ participated in the samples collection. WJC designed the study, perform the data analysis and wrote the manuscript. All authors read and approved the final manuscript.</p></p></div></div><div id="idm139784370358720aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139784370358720aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Feng Mu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.gro.scimoneg@gnefum" class="oemail">nc.gro.scimoneg@gnefum</a></span>.</p><p><span class="fm-affl">Dongsheng Niu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.ca.imb@uinsd" class="oemail">nc.ca.imb@uinsd</a></span>.</p><p><span class="fm-affl">Jingsong Mu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@gnosgnijum" class="oemail">moc.oohay@gnosgnijum</a></span>.</p><p><span class="fm-affl">Bo He, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.gro.scimoneg@beh" class="oemail">nc.gro.scimoneg@beh</a></span>.</p><p><span class="fm-affl">Weiguo Han, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.ca.imb@nahgw" class="oemail">nc.ca.imb@nahgw</a></span>.</p><p><span class="fm-affl">Baoxing Fan, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.362@gnixbnaf" class="oemail">ten.362@gnixbnaf</a></span>.</p><p><span class="fm-affl">Shengyong Huang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.gro.scimoneg@ysgnauh" class="oemail">nc.gro.scimoneg@ysgnauh</a></span>.</p><p><span class="fm-affl">Yan Qiu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.oohay@nc444uiq" class="oemail">nc.moc.oohay@nc444uiq</a></span>.</p><p><span class="fm-affl">Bo You, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.gro.scimoneg@buoY" class="oemail">nc.gro.scimoneg@buoY</a></span>.</p><p><span class="fm-affl">Weijun Chen, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.gro.scimoneg@jwnehc" class="oemail">nc.gro.scimoneg@jwnehc</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">WHO  . <span class="ref-journal">Cumulative number of reported cases of severe acute respiratory syndrome (SARS)</span> 2003.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Cumulative+number+of+reported+cases+of+severe+acute+respiratory+syndrome+(SARS)&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">WHO  Severe acute respiratory syndrome (SARS) <span><span class="ref-journal">Wkly Epidemiol Rec. </span>2003;<span class="ref-vol">78</span>:86.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Wkly+Epidemiol+Rec&amp;title=Severe+acute+respiratory+syndrome+(SARS)&amp;volume=78&amp;publication_year=2003&amp;pages=86&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Marra MA, Jones SJM, Astell CR, Holt RA, Wilson AB, Butterfield YSN, Khattra J, Jennifer KA, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS. The Genome sequence of the SARS-associated coronavirus. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1399\xe2\x80\x931404. doi: 10.1126/science.1085953.</span> [<a href="/pubmed/12730501" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1085953" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+Genome+sequence+of+the+SARS-associated+coronavirus&amp;author=MA+Marra&amp;author=SJM+Jones&amp;author=CR+Astell&amp;author=RA+Holt&amp;author=AB+Wilson&amp;volume=300&amp;publication_year=2003&amp;pages=1399-1404&amp;pmid=12730501&amp;doi=10.1126/science.1085953&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY, SARS study group  Coronavirus as a possible cause of severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1319\xe2\x80\x931325. doi: 10.1016/S0140-6736(03)13077-2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112372/">PMC free article</a>]</span> [<a href="/pubmed/12711465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)13077-2" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Coronavirus+as+a+possible+cause+of+severe+acute+respiratory+syndrome&amp;author=JS+Peiris&amp;author=ST+Lai&amp;author=LL+Poon&amp;author=Y+Guan&amp;author=LY+Yam&amp;volume=361&amp;publication_year=2003&amp;pages=1319-1325&amp;pmid=12711465&amp;doi=10.1016/S0140-6736(03)13077-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Qin E, Zhu Q, Yu M, Fan B, Chang G, Si B, Yang B, Peng W, Jiang T, Liu B, Deng Y, Liu H, Zhang Y, Wang C, Li Y, Gan Y, Li X, L&#x000fc; F, Tan G, Cao W, Yang R, Wang J, Li W, Xu Z, Li Y, Wu Q, Lin W, Han Y, Li G, Li W, et al.  A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01) <span><span class="ref-journal">Chin Sci Bulltin. </span>2003;<span class="ref-vol">48</span>:941\xe2\x80\x93948. doi: 10.1007/BF03184203.</span> [<a href="//dx.doi.org/10.1007%2FBF03184203" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chin+Sci+Bulltin&amp;title=A+complete+sequence+and+comparative+analysis+of+a+SARS-associated+virus+(Isolate+BJ01)&amp;author=E+Qin&amp;author=Q+Zhu&amp;author=M+Yu&amp;author=B+Fan&amp;author=G+Chang&amp;volume=48&amp;publication_year=2003&amp;pages=941-948&amp;doi=10.1007/BF03184203&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Pe&#x000f1;aranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, G&#x000fc;nther S, et al.  Characterization of a novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1394\xe2\x80\x931399. doi: 10.1126/science.1085952.</span> [<a href="/pubmed/12730500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1085952" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Characterization+of+a+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&amp;author=PA+Rota&amp;author=MS+Oberste&amp;author=SS+Monroe&amp;author=WA+Nix&amp;author=R+Campagnoli&amp;volume=300&amp;publication_year=2003&amp;pages=1394-1399&amp;pmid=12730500&amp;doi=10.1126/science.1085952&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Chen W, Xu Z, Mu J, Yang L, Gan H, Mu F, Fan B, He B, Huang S, You B, Yang Y, Tang X, Qiu L, Qiu Y, Wen J, Fang J, Wang J. Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. <span><span class="ref-journal">Journal of Medical Microbiology. </span>2004;<span class="ref-vol">53</span>:435\xe2\x80\x93438. doi: 10.1099/jmm.0.45561-0.</span> [<a href="/pubmed/15096554" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1099%2Fjmm.0.45561-0" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Medical+Microbiology&amp;title=Antibody+response+and+viraemia+during+the+course+of+severe+acute+respiratory+syndrome+(SARS)-associated+coronavirus+infection&amp;author=W+Chen&amp;author=Z+Xu&amp;author=J+Mu&amp;author=L+Yang&amp;author=H+Gan&amp;volume=53&amp;publication_year=2004&amp;pages=435-438&amp;pmid=15096554&amp;doi=10.1099/jmm.0.45561-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, Yang Y, Qin E, You B, Li W, Li X, Huang S, Yang R, Zhang X, Yang L, Zhang T, Yin Y, Cui X, Tang X, Wang L, He B, Ma L, Lei T, Zeng C, Fang J, Yu J, Wang J, Yang H, West MB, Bhatnagar A, et al.  Assessment of Immunoreactive Synthetic Peptides from the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus. <span><span class="ref-journal">Clinical Chemistry. </span>2003;<span class="ref-vol">49</span>(12):1989\xe2\x80\x931996. doi: 10.1373/clinchem.2003.023184.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7108193/">PMC free article</a>]</span> [<a href="/pubmed/14633869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1373%2Fclinchem.2003.023184" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clinical+Chemistry&amp;title=Assessment+of+Immunoreactive+Synthetic+Peptides+from+the+Structural+Proteins+of+Severe+Acute+Respiratory+Syndrome+Coronavirus&amp;author=J+Wang&amp;author=J+Wen&amp;author=J+Li&amp;author=J+Yin&amp;author=Q+Zhu&amp;volume=49&amp;issue=12&amp;publication_year=2003&amp;pages=1989-1996&amp;pmid=14633869&amp;doi=10.1373/clinchem.2003.023184&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Chan KH, Tam VK, Peiris JS, Yuen KY. Detection of specific antibodies to SARS coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. <span><span class="ref-journal">J Clin Microbiol. </span>2004;<span class="ref-vol">42</span>:2306\xe2\x80\x932309. doi: 10.1128/JCM.42.5.2306-2309.2004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC404667/">PMC free article</a>]</span> [<a href="/pubmed/15131220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.42.5.2306-2309.2004" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Detection+of+specific+antibodies+to+SARS+coronavirus+nucleocapsid+protein+for+serodiagnosis+of+SARS+coronavirus+pneumonia&amp;author=PC+Woo&amp;author=SK+Lau&amp;author=BH+Wong&amp;author=HW+Tsoi&amp;author=AM+Fung&amp;volume=42&amp;publication_year=2004&amp;pages=2306-2309&amp;pmid=15131220&amp;doi=10.1128/JCM.42.5.2306-2309.2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Yu F, Le MQ, Inoue S, Thai HT, Hasebe F, Del Carmen Parquet M, Morita K. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. <span><span class="ref-journal">Clin Diagn Lab Immunol. </span>2005;<span class="ref-vol">12</span>(7):848\xe2\x80\x9354.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1182204/">PMC free article</a>]</span> [<a href="/pubmed/16002634" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Diagn+Lab+Immunol&amp;title=Evaluation+of+inapparent+nosocomial+severe+acute+respiratory+syndrome+coronavirus+infection+in+Vietnam+by+use+of+highly+specific+recombinant+truncated+nucleocapsid+protein-based+enzyme-linked+immunosorbent+assay&amp;author=F+Yu&amp;author=MQ+Le&amp;author=S+Inoue&amp;author=HT+Thai&amp;author=F+Hasebe&amp;volume=12&amp;issue=7&amp;publication_year=2005&amp;pages=848-54&amp;pmid=16002634&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="mixed-citation">Lei Shi, Qipeng Zhang, Wei Rui, Ming Lu: Structure and function Analysis of SARS-CoV spike protein. [<a href="http://cmbi.bjmu.edu.cn/cmbidata/sars/sars_secstructure/spike.htm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://cmbi.bjmu.edu.cn/cmbidata/sars/sars_secstructure/spike.htm</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. <span><span class="ref-journal">J Virol Methods. </span>2005;<span class="ref-vol">128</span>(1&#x02013;2):21\xe2\x80\x9328. doi: 10.1016/j.jviromet.2005.03.021.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112802/">PMC free article</a>]</span> [<a href="/pubmed/15885812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jviromet.2005.03.021" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Monoclonal+antibodies+to+SARS-associated+coronavirus+(SARS-CoV):+Identification+of+neutralizing+and+antibodies+reactive+to+S,+N,+M+and+E+viral+proteins&amp;author=RA+Tripp&amp;author=LM+Haynes&amp;author=D+Moore&amp;author=B+Anderson&amp;author=A+Tamin&amp;volume=128&amp;issue=1&#x02013;2&amp;publication_year=2005&amp;pages=21-28&amp;pmid=15885812&amp;doi=10.1016/j.jviromet.2005.03.021&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Liu SJ, Leng CH, Lien SP, Chi HY, Huang CY, Lin CL, Lian WC, Chen CJ, Hsieh SL, Chong P. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates. <span><span class="ref-journal">Vaccine. </span>2006;<span class="ref-vol">24</span>:3100\xe2\x80\x933108. doi: 10.1016/j.vaccine.2006.01.058.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7115648/">PMC free article</a>]</span> [<a href="/pubmed/16494977" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.vaccine.2006.01.058" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunological+characterizations+of+the+nucleocapsid+protein+based+SARS+vaccine+candidates&amp;author=SJ+Liu&amp;author=CH+Leng&amp;author=SP+Lien&amp;author=HY+Chi&amp;author=CY+Huang&amp;volume=24&amp;publication_year=2006&amp;pages=3100-3108&amp;pmid=16494977&amp;doi=10.1016/j.vaccine.2006.01.058&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, Koup RA, Bailer RT, Wu CY. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. <span><span class="ref-journal">Virology. </span>2006;<span class="ref-vol">351</span>:466\xe2\x80\x93475. doi: 10.1016/j.virol.2006.03.036.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7111820/">PMC free article</a>]</span> [<a href="/pubmed/16690096" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virol.2006.03.036" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Long-lived+memory+T+lymphocyte+responses+against+SARS+coronavirus+nucleocapsid+protein+in+SARS-recovered+patients&amp;author=H+Peng&amp;author=LT+Yang&amp;author=LY+Wang&amp;author=J+Li&amp;author=J+Huang&amp;volume=351&amp;publication_year=2006&amp;pages=466-475&amp;pmid=16690096&amp;doi=10.1016/j.virol.2006.03.036&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Zhi Y, Kobinger GP, Jordan H, Suchma K, Weiss SR, Shen H, Schumer G, Gao G, Boyer JL, Crystal RG, Wilson JM. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. <span><span class="ref-journal">Virology. </span>2005;<span class="ref-vol">335</span>:34\xe2\x80\x9345. doi: 10.1016/j.virol.2005.01.050.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7111773/">PMC free article</a>]</span> [<a href="/pubmed/15823604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virol.2005.01.050" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Identification+of+murine+CD8+T+cell+epitopes+in+codon-optimized+SARS-associated+coronavirus+spike+protein&amp;author=Y+Zhi&amp;author=GP+Kobinger&amp;author=H+Jordan&amp;author=K+Suchma&amp;author=SR+Weiss&amp;volume=335&amp;publication_year=2005&amp;pages=34-45&amp;pmid=15823604&amp;doi=10.1016/j.virol.2005.01.050&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Sestak K, Meister RK, Hayes JR, Kim L, Lewis PA, Myers G, Saif LG. Active immunity and T-cell populations in pigs intraperitoneally inoculated with baculovirus-expressed transmissible gastroenteritis virus structural proteins. <span><span class="ref-journal">Vet Immunol Immunopathol. </span>1999;<span class="ref-vol">70</span>:203\xe2\x80\x93221. doi: 10.1016/S0165-2427(99)00074-4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7119614/">PMC free article</a>]</span> [<a href="/pubmed/10507362" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0165-2427(99)00074-4" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vet+Immunol+Immunopathol&amp;title=Active+immunity+and+T-cell+populations+in+pigs+intraperitoneally+inoculated+with+baculovirus-expressed+transmissible+gastroenteritis+virus+structural+proteins&amp;author=K+Sestak&amp;author=RK+Meister&amp;author=JR+Hayes&amp;author=L+Kim&amp;author=PA+Lewis&amp;volume=70&amp;publication_year=1999&amp;pages=203-221&amp;pmid=10507362&amp;doi=10.1016/S0165-2427(99)00074-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Chen WJ, Niu DS, Zhang XY, Chen ML, Cui H, Wei WJ, Wen BH, Chen XR. Recombinant 56-Kilodalton Major Outer Membrane Protein Antigen of <em>Orientia tsutsugamushi</em> Shanxi and Its Antigenicity. <span><span class="ref-journal">Infection and Immunity. </span>2003;<span class="ref-vol">8</span>:4772\xe2\x80\x934779. doi: 10.1128/IAI.71.8.4772-4779.2003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC166048/">PMC free article</a>]</span> [<a href="/pubmed/12874360" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FIAI.71.8.4772-4779.2003" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection+and+Immunity&amp;title=Recombinant+56-Kilodalton+Major+Outer+Membrane+Protein+Antigen+of+Orientia+tsutsugamushi+Shanxi+and+Its+Antigenicity&amp;author=WJ+Chen&amp;author=DS+Niu&amp;author=XY+Zhang&amp;author=ML+Chen&amp;author=H+Cui&amp;volume=8&amp;publication_year=2003&amp;pages=4772-4779&amp;doi=10.1128/IAI.71.8.4772-4779.2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1979;<span class="ref-vol">76</span>:4350\xe2\x80\x934354. doi: 10.1073/pnas.76.9.4350.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC411572/">PMC free article</a>]</span> [<a href="/pubmed/388439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.76.9.4350" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Electrophoretic+transfer+of+proteins+from+polyacrylamide+gels+to+nitrocellulose+sheets:+procedure+and+some+applications&amp;author=H+Towbin&amp;author=T+Staehelin&amp;author=J+Gordon&amp;volume=76&amp;publication_year=1979&amp;pages=4350-4354&amp;pmid=388439&amp;doi=10.1073/pnas.76.9.4350&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Jin DY, Li MF.  <span class="ref-journal">Molecular Cloning: A Laboratory Manual.</span> 2. Beijing: Press of science; 1992.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Molecular+Cloning:+A+Laboratory+Manual&amp;author=DY+Jin&amp;author=MF+Li&amp;publication_year=1992&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Du P.  <span class="ref-journal">Medical experimental virology.</span> Shanghai, China: Shanghai Association of Microbiology; 1982. pp. 211\xe2\x80\x93212. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Medical+experimental+virology&amp;author=P+Du&amp;publication_year=1982&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Andreoni M, Faircloth M, Vugler L, Britt WJ. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. <span><span class="ref-journal">J Virol Methods. </span>1989;<span class="ref-vol">23</span>:157\xe2\x80\x93167. doi: 10.1016/0166-0934(89)90129-8.</span> [<a href="/pubmed/2542350" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0166-0934(89)90129-8" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=A+rapid+microneutralization+assay+for+the+measurement+of+neutralizing+antibody+reactive+with+human+cytomegalovirus&amp;author=M+Andreoni&amp;author=M+Faircloth&amp;author=L+Vugler&amp;author=WJ+Britt&amp;volume=23&amp;publication_year=1989&amp;pages=157-167&amp;pmid=2542350&amp;doi=10.1016/0166-0934(89)90129-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. <span><span class="ref-journal">Am J Hyg. </span>1938;<span class="ref-vol">27</span>:493\xe2\x80\x93497.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hyg&amp;title=A+simple+method+of+estimating+fifty+percent+endpoints&amp;author=LJ+Reed&amp;author=H+Muench&amp;volume=27&amp;publication_year=1938&amp;pages=493-497&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Shuhan Sun.  <span class="ref-journal">Nuclear vaccine.</span> Shanghai: Press of the Second Military Medicine University; 2000. p. 114. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Nuclear+vaccine&amp;author=Sun+Shuhan&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Chen WJ, Xu ZY, Mu JS, He B, Yang L, Lin L, Meng SF, Mu F, Gan HX, Huang SY, Wen J, Fang JQ, Wang J. Real-Time Quantitative Fluorescent Reverse Transcriptase-PCR for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus RNA. <span><span class="ref-journal">Molecular Diagnosis. </span>2004;<span class="ref-vol">8</span>(4):231\xe2\x80\x93235. doi: 10.1007/BF03260067.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7100218/">PMC free article</a>]</span> [<a href="/pubmed/15887978" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2FBF03260067" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Diagnosis&amp;title=Real-Time+Quantitative+Fluorescent+Reverse+Transcriptase-PCR+for+Detection+of+Severe+Acute+Respiratory+Syndrome-Associated+Coronavirus+RNA&amp;author=WJ+Chen&amp;author=ZY+Xu&amp;author=JS+Mu&amp;author=B+He&amp;author=L+Yang&amp;volume=8&amp;issue=4&amp;publication_year=2004&amp;pages=231-235&amp;pmid=15887978&amp;doi=10.1007/BF03260067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Sun ZF, Meng XJ. Antigenic Cross-Reactivity between the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus and Polyclonal Antisera of Antigenic Group I Animal Coronaviruses: Implication for SARS Diagnosis. <span><span class="ref-journal">Journal of Clinical Microbiology. </span>2004;<span class="ref-vol">42</span>(5):2351\xe2\x80\x932352. doi: 10.1128/JCM.42.5.2351-2352.2004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC404591/">PMC free article</a>]</span> [<a href="/pubmed/15131233" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.42.5.2351-2352.2004" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Clinical+Microbiology&amp;title=Antigenic+Cross-Reactivity+between+the+Nucleocapsid+Protein+of+Severe+Acute+Respiratory+Syndrome+(SARS)+Coronavirus+and+Polyclonal+Antisera+of+Antigenic+Group+I+Animal+Coronaviruses:+Implication+for+SARS+Diagnosis&amp;author=ZF+Sun&amp;author=XJ+Meng&amp;volume=42&amp;issue=5&amp;publication_year=2004&amp;pages=2351-2352&amp;pmid=15131233&amp;doi=10.1128/JCM.42.5.2351-2352.2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, SARS Working Group  A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. <span><span class="ref-journal">The New England Journal of Medicine. </span>2003;<span class="ref-vol">348</span>(20):1953\xe2\x80\x931966. doi: 10.1056/NEJMoa030781.</span> [<a href="/pubmed/12690092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030781" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+New+England+Journal+of+Medicine&amp;title=A+Novel+Coronavirus+Associated+with+Severe+Acute+Respiratory+Syndrome&amp;author=TG+Ksiazek&amp;author=D+Erdman&amp;author=CS+Goldsmith&amp;author=SR+Zaki&amp;author=T+Peret&amp;volume=348&amp;issue=20&amp;publication_year=2003&amp;pages=1953-1966&amp;pmid=12690092&amp;doi=10.1056/NEJMoa030781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">He Q, Chong KH, Chng HH, Leung B, Ling AE, Wei T, Chan SW, Ooi EE, Kwang J. Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. <span><span class="ref-journal">Clin Diagn Lab Immunol. </span>2004;<span class="ref-vol">11</span>:417\xe2\x80\x93422.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC371214/">PMC free article</a>]</span> [<a href="/pubmed/15013997" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Diagn+Lab+Immunol&amp;title=Development+of+a+Western+blot+assay+for+detection+of+antibodies+against+coronavirus+causing+severe+acute+respiratory+syndrome&amp;author=Q+He&amp;author=KH+Chong&amp;author=HH+Chng&amp;author=B+Leung&amp;author=AE+Ling&amp;volume=11&amp;publication_year=2004&amp;pages=417-422&amp;pmid=15013997&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Kao RY, Chan KH, Peiris JS, Yuen KY. Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus Pneumonia. <span><span class="ref-journal">J Clin Microbiol. </span>2005;<span class="ref-vol">43</span>(7):3054\xe2\x80\x933058. doi: 10.1128/JCM.43.7.3054-3058.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1169156/">PMC free article</a>]</span> [<a href="/pubmed/16000415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.43.7.3054-3058.2005" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Differential+Sensitivities+of+Severe+Acute+Respiratory+Syndrome+(SARS)+Coronavirus+Spike+Polypeptide+Enzyme-Linked+Immunosorbent+Assay+(ELISA)+and+SARS+Coronavirus+Nucleocapsid+Protein+ELISA+for+Serodiagnosis+of+SARS+Coronavirus+Pneumonia&amp;author=PC+Woo&amp;author=SK+Lau&amp;author=BH+Wong&amp;author=HW+Tsoi&amp;author=AM+Fung&amp;volume=43&amp;issue=7&amp;publication_year=2005&amp;pages=3054-3058&amp;pmid=16000415&amp;doi=10.1128/JCM.43.7.3054-3058.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Wu HS, Hsieh YC, Su IJ, Lin TH, Chiu SC, Hsu YF, Lin JH, Wang MC, Chen JY, Hsiao PW, Chang GD, Wang AH, Ting HW, Chou CM, Huang CJ. Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. <span><span class="ref-journal">J Biomed Sci. </span>2004;<span class="ref-vol">11</span>(1):117\xe2\x80\x93126. doi: 10.1007/BF02256554.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7089234/">PMC free article</a>]</span> [<a href="/pubmed/14730215" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2FBF02256554" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomed+Sci&amp;title=Early+detection+of+antibodies+against+various+structural+proteins+of+the+SARS-associated+coronavirus+in+SARS+patients&amp;author=HS+Wu&amp;author=YC+Hsieh&amp;author=IJ+Su&amp;author=TH+Lin&amp;author=SC+Chiu&amp;volume=11&amp;issue=1&amp;publication_year=2004&amp;pages=117-126&amp;pmid=14730215&amp;doi=10.1007/BF02256554&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. <span><span class="ref-journal">Virology. </span>2001;<span class="ref-vol">279</span>(2):371\xe2\x80\x93374. doi: 10.1006/viro.2000.0757.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7133764/">PMC free article</a>]</span> [<a href="/pubmed/11162792" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fviro.2000.0757" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Coronavirus+spike+proteins+in+viral+entry+and+pathogenesis&amp;author=TM+Gallagher&amp;author=MJ+Buchmeier&amp;volume=279&amp;issue=2&amp;publication_year=2001&amp;pages=371-374&amp;pmid=11162792&amp;doi=10.1006/viro.2000.0757&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Hideyuki Kubo, Yasuko K. Yamada and Fumihiro Taguchi. Localization of Neutralizing Epitopes and the Receptor-Binding Site within the Amino-Terminal 330 Amino Acids of the Murine Coronavirus Spike Protein. <span><span class="ref-journal">Journal of Virology. </span>1994;<span class="ref-vol">68</span>(9):5403\xe2\x80\x935410.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC236940/">PMC free article</a>]</span> [<a href="/pubmed/7520090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Virology&amp;title=Yamada+and+Fumihiro+Taguchi.+Localization+of+Neutralizing+Epitopes+and+the+Receptor-Binding+Site+within+the+Amino-Terminal+330+Amino+Acids+of+the+Murine+Coronavirus+Spike+Protein&amp;author=Kubo+Hideyuki&amp;author=K+Yasuko&amp;volume=68&amp;issue=9&amp;publication_year=1994&amp;pages=5403-5410&amp;pmid=7520090&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">428</span>:561\xe2\x80\x93564. doi: 10.1038/nature02463.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095382/">PMC free article</a>]</span> [<a href="/pubmed/15024391" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnature02463" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+DNA+vaccine+induces+SARS+coronavirus+neutralization+and+protective+immunity+in+mice&amp;author=ZY+Yang&amp;author=WP+Kong&amp;author=Y+Huang&amp;author=A+Roberts&amp;author=BR+Murphy&amp;volume=428&amp;publication_year=2004&amp;pages=561-564&amp;pmid=15024391&amp;doi=10.1038/nature02463&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Park S, Sestak K, Hodgins DC, Shoup DI, Ward LA, Jackwood DJ, Saif LJ. Immune response of sows vaccinated with attenuated transmissible gastroenteritis virus (TGEV) and recombinant TGEV spike protein vaccines and protection of their suckling pigs against virulent TGEV challenge exposure. <span><span class="ref-journal">Am J Vet Res. </span>1998;<span class="ref-vol">59</span>(8):1002\xe2\x80\x931008.</span> [<a href="/pubmed/9706204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Vet+Res&amp;title=Immune+response+of+sows+vaccinated+with+attenuated+transmissible+gastroenteritis+virus+(TGEV)+and+recombinant+TGEV+spike+protein+vaccines+and+protection+of+their+suckling+pigs+against+virulent+TGEV+challenge+exposure&amp;author=S+Park&amp;author=K+Sestak&amp;author=DC+Hodgins&amp;author=DI+Shoup&amp;author=LA+Ward&amp;volume=59&amp;issue=8&amp;publication_year=1998&amp;pages=1002-1008&amp;pmid=9706204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2613400&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2613400/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2613400/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2613400/pdf/12866_2008_Article_640.pdf">PDF (2.1M)</a></li> | <li><a href="#" data-citationid="PMC2613400" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2613400%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2613400%2F&amp;text=The%20expression%20and%20antigenicity%20of%20a%20truncated%20spike-nucleocapsid%20fusion%20protein%20of%20severe%20acute%20respiratory%20syndrome-associated%20coronavirus"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2613400%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19038059" data-aiid="7090932" data-aid="2613400" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2613400" data-md5="90df67fc3920e2b81762a57f6c904bc0"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T10:54:37-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A6DD3E99C19110000000000C200C2&amp;ncbi_session=8A1A6DD3E99C32D1_0194SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2613400%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2613400/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A6DD3E99C32D1_0194SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'